{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:07:44Z","timestamp":1788908864800,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05245-0","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:37:34Z","timestamp":1782319054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel lactylation-related gene signature deciphers the immunosuppressive microenvironment and stratifies precision therapy in colorectal cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"Chi","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"issue":"3","key":"5245_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"5245_CR2","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3390\/cancers13092025","volume":"13","author":"T Sawicki","year":"2021","unstructured":"Sawicki T, Ruszkowska M, Danielewicz A, Niedzwiedzka E, Arlukowicz T, Przybylowicz KE. A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers. 2021;13(9):2025. https:\/\/doi.org\/10.3390\/cancers13092025.","journal-title":"Cancers"},{"issue":"1","key":"5245_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"key":"5245_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102307","volume":"53","author":"A Meyiah","year":"2025","unstructured":"Meyiah A, Khan FI, Alfaki DA, Murshed K, Raza A, Elkord E. The colorectal cancer microenvironment: preclinical progress in identifying targets for cancer therapy. Transl Oncol. 2025;53:102307. https:\/\/doi.org\/10.1016\/j.tranon.2025.102307.","journal-title":"Transl Oncol"},{"key":"5245_CR5","doi-asserted-by":"publisher","first-page":"2400077","DOI":"10.1200\/oa-24-00077","volume":"2","author":"K Pum","year":"2025","unstructured":"Pum K, LaRocca CJ, Goffredo P, Subramanian S, Lou E, Prakash A. Immune checkpoint blockade therapies for colorectal cancer: current strategies and emerging approaches. JCO Oncol Adv. 2025;2:2400077. https:\/\/doi.org\/10.1200\/oa-24-00077.","journal-title":"JCO Oncol Adv"},{"issue":"1","key":"5245_CR6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/s12876-022-02511-7","volume":"22","author":"Y Li","year":"2022","unstructured":"Li Y, Du Y, Xue C, Wu P, Du N, Zhu G, et al. Efficacy and safety of anti-pd-1\/pd-l1 therapy in the treatment of advanced colorectal cancer: a meta-analysis. BMC Gastroenterol. 2022;22(1):431. https:\/\/doi.org\/10.1186\/s12876-022-02511-7.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"5245_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW. The Warburg effect: How does it benefit cancer cells? Trends Biochem Sci. 2016;41(3):211\u20138. https:\/\/doi.org\/10.1016\/j.tibs.2015.12.001.","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"5245_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","volume":"7","author":"X Li","year":"2022","unstructured":"Li X, Yang Y, Zhang B, Lin X, Fu X, An Y. Lactate metabolism in human health and disease. Signal Transduct Target Ther. 2022;7(1):305. https:\/\/doi.org\/10.1038\/s41392-022-01151-3.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"5245_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","volume":"10","author":"J Chen","year":"2025","unstructured":"Chen J, Huang Z, Chen Y, Liu L, Xie D, He J. Lactate and lactylation in cancer. Signal Transduct Target Ther. 2025;10(1):38. https:\/\/doi.org\/10.1038\/s41392-024-02082-x.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"5245_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41420-024-01865-z","volume":"10","author":"X Chen","year":"2024","unstructured":"Chen X, Ma Z, Yi Z, Fan H, Duan J, Wu H. The effects of metabolism on the immune microenvironment in colorectal cancer. Cell Death Discovery. 2024;10(1):118. https:\/\/doi.org\/10.1038\/s41420-024-01865-z.","journal-title":"Cell Death Discovery"},{"key":"5245_CR11","doi-asserted-by":"publisher","first-page":"1089918","DOI":"10.3389\/fendo.2022.1089918","volume":"13","author":"Q Sun","year":"2023","unstructured":"Sun Q, Wu J, Zhu G, Wu Y, Chen H, Xu P. Lactate-related metabolic reprogramming and immune regulation in colorectal cancer. Front Endocrinol. 2023;13:1089918. https:\/\/doi.org\/10.3389\/fendo.2022.1089918.","journal-title":"Front Endocrinol"},{"key":"5245_CR12","doi-asserted-by":"publisher","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575\u201380. https:\/\/doi.org\/10.1038\/s41586-019-1678-1.","DOI":"10.1038\/s41586-019-1678-1"},{"key":"5245_CR13","doi-asserted-by":"publisher","first-page":"70226","DOI":"10.1002\/mco2.70226","volume":"6","author":"X Chen","year":"2025","unstructured":"Chen X, Yuan Y, Zhou F, Li L, Pu J, Zeng Y, et al. Lactylation: from homeostasis to pathological implications and therapeutic strategies. MedComm. 2025;6:70226. https:\/\/doi.org\/10.1002\/mco2.70226.","journal-title":"MedComm"},{"key":"5245_CR14","doi-asserted-by":"publisher","first-page":"1598232","DOI":"10.3389\/fcell.2025.1598232","volume":"13","author":"Z Gou","year":"2025","unstructured":"Gou Z, Sun Q, Li J. Exploring lactylation and cancer biology: insights from pathogenesis to clinical applications. Frontiers Cell Develop Biol. 2025;13:1598232. https:\/\/doi.org\/10.3389\/fcell.2025.1598232.","journal-title":"Frontiers Cell Develop Biol"},{"key":"5245_CR15","doi-asserted-by":"publisher","unstructured":"Zhao L, Qi H, Lv H, et al. Lactylation in health and disease: physiological or pathological? Theranostics. 2025;15(5):1787\u2013821. https:\/\/doi.org\/10.7150\/thno.105353.","DOI":"10.7150\/thno.105353"},{"key":"5245_CR16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s12672-025-02359-9","volume":"16","author":"Y Sun","year":"2025","unstructured":"Sun Y, Yang X, Kong F, Dong F, Li N. The mechanisms and effects of lactylation modification in different kinds of cancers. Discover Oncol. 2025;16:560. https:\/\/doi.org\/10.1007\/s12672-025-02359-9.","journal-title":"Discover Oncol"},{"issue":"1","key":"5245_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13059-021-02308-z","volume":"22","author":"J Yu","year":"2021","unstructured":"Yu J, Chai P, Xie M, Ge S, Ruan J, Fan X. Histone lactylation drives oncogenesis by facilitating m6a reader protein ythdf2 expression in ocular melanoma. Genome Biol. 2021;22(1):85. https:\/\/doi.org\/10.1186\/s13059-021-02308-z.","journal-title":"Genome Biol"},{"key":"5245_CR18","doi-asserted-by":"publisher","first-page":"1384948","DOI":"10.3389\/fimmu.2024.1384948","volume":"15","author":"H Zha","year":"2024","unstructured":"Zha H, Wang Z, Li Y, Zhang L, Zhang Y. A review of lactate-lactylation in malignancy: its potential in immunotherapy. Front Immunol. 2024;15:1384948. https:\/\/doi.org\/10.3389\/fimmu.2024.1384948.","journal-title":"Front Immunol"},{"key":"5245_CR19","doi-asserted-by":"publisher","unstructured":"Wang T, Zhang W, Liu J, Zhao Y, Zhao Z, Zhang H. Dnmbp-as1\/hsa-mir-30a-5p\/pgc1 $$\\alpha $$ axis suppresses tumor progression of colorectal cancer by inhibiting pkm2-mediated warburg effect and enhancing anti-pd-1 therapy efficacy. Cell Death Discovery. 2025;11:299. https:\/\/doi.org\/10.1038\/s41420-025-02561-2.","DOI":"10.1038\/s41420-025-02561-2"},{"key":"5245_CR20","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/s1470-2045(25)00239-6","volume":"26","author":"J Li","year":"2025","unstructured":"Li J, Pan Y, Guo F, Zhang P, Zhang S, Zhang X. Patterns in genomic mutations among patients with early-onset colorectal cancer: an international, multicohort, observational study. Lancet Oncol. 2025;26:1055\u201366. https:\/\/doi.org\/10.1016\/s1470-2045(25)00239-6.","journal-title":"Lancet Oncol"},{"issue":"5","key":"5245_CR21","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3390\/ph16050644","volume":"16","author":"Z Cheng","year":"2023","unstructured":"Cheng Z, Huang H, Li M, Liang X, Tan Y, Chen Y. Lactylation-related gene signature effectively predicts prognosis and treatment responsiveness in hepatocellular carcinoma. Pharmaceuticals (Basel). 2023;16(5):644. https:\/\/doi.org\/10.3390\/ph16050644.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"5245_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1\u201322. https:\/\/doi.org\/10.18637\/jss.v033.i01.","journal-title":"J Stat Softw"},{"key":"5245_CR23","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.18632\/aging.102931","volume":"12","author":"Z Meng","year":"2020","unstructured":"Meng Z, Ren D, Zhang K, et al. Using estimate algorithm to establish an 8-mrna signature prognosis prediction system and identify immunocyte infiltration-related genes in pancreatic adenocarcinoma. Aging (Albany NY). 2020;12:5048\u201370. https:\/\/doi.org\/10.18632\/aging.102931.","journal-title":"Aging (Albany NY)"},{"key":"5245_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. Gsva: gene set variation analysis for microarray and rna-seq data. BMC Bioinform. 2013;14:7. https:\/\/doi.org\/10.1186\/1471-2105-14-7.","journal-title":"BMC Bioinform"},{"issue":"4","key":"5245_CR25","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, et al. The immune landscape of cancer. Immunity. 2018;48(4):812\u201383014. https:\/\/doi.org\/10.1016\/j.immuni.2018.03.023.","journal-title":"Immunity"},{"issue":"11","key":"5245_CR26","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1038\/ncomms3995","volume":"6","author":"R Milo","year":"2022","unstructured":"Milo R, Cohn Z, Langer S, Chaker S, Perelson P. Spatial reconstruction of single-cell gene expression data. Nat Commun. 2022;6(11):3995. https:\/\/doi.org\/10.1038\/ncomms3995.","journal-title":"Nat Commun"},{"issue":"12","key":"5245_CR27","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with harmony. Nat Methods. 2019;16(12):1289\u201396. https:\/\/doi.org\/10.1038\/s41592-019-0619-0.","journal-title":"Nat Methods"},{"issue":"1","key":"5245_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nbt.4314","volume":"37","author":"E Becht","year":"2018","unstructured":"Becht E, McInnes L, Healy J, Dutertre CA, Kwok IWH, Ng LG, et al. Dimensionality reduction for visualizing single-cell data using umap. Nat Biotechnol. 2018;37(1):38\u201344. https:\/\/doi.org\/10.1038\/nbt.4314.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"5245_CR29","first-page":"65","volume":"5","author":"F John","year":"2023","unstructured":"John F, Bontempi P, Ortiz P. Limma powers differential expression analyses for rna-sequencing and microarray studies. Nature Biotech. 2023;5(7):65\u201385.","journal-title":"Nature Biotech"},{"issue":"3","key":"5245_CR30","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3389\/fgene.2024.1029","volume":"7","author":"J Wang","year":"2024","unstructured":"Wang J, Li D, Fu S. clusterprofiler 4.0: a universal enrichment tool for interpreting omics data. Front Genet. 2024;7(3):1029. https:\/\/doi.org\/10.3389\/fgene.2024.1029.","journal-title":"Front Genet"},{"issue":"11","key":"5245_CR31","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747\u201356. https:\/\/doi.org\/10.1101\/gr.239244.118.","journal-title":"Genome Res"},{"issue":"5","key":"5245_CR32","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterprofiler: an r package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"issue":"6","key":"5245_CR33","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/bib\/bbab260","volume":"22","author":"D Maeser","year":"2021","unstructured":"Maeser D, Gruener RF, Huang RS. oncopredict: an r package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021;22(6):260. https:\/\/doi.org\/10.1093\/bib\/bbab260.","journal-title":"Brief Bioinform"},{"key":"5245_CR34","doi-asserted-by":"publisher","unstructured":"Garnett MJ, Edelman EJ, Heidorn SJ, Greenman CD, Dastur A, Gentry B, Systematic identification of genomic markers of drug sensitivity in cancer cells. Nucleic Acids Res 41(Database issue), 2013;955\u2013961 https:\/\/doi.org\/10.1093\/nar\/gks1111","DOI":"10.1093\/nar\/gks1111"},{"issue":"8","key":"5245_CR35","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/jco.2007.12.9791","volume":"26","author":"A Iasonos","year":"2008","unstructured":"Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364\u201370. https:\/\/doi.org\/10.1200\/jco.2007.12.9791.","journal-title":"J Clin Oncol"},{"issue":"5","key":"5245_CR36","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"Brand A, Singer K, Koehl GE, Kolitzus M, Schoenhammer G, Thiel A. Ldha-associated lactic acid production blunts tumor immunosurveillance by t and nk cells. Cell Metab. 2016;24(5):657\u201371. https:\/\/doi.org\/10.1016\/j.cmet.2016.08.011.","journal-title":"Cell Metab"},{"issue":"1","key":"5245_CR37","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","volume":"9","author":"B Wu","year":"2024","unstructured":"Wu B, Zhang B, Li B, Guo Y. Cold and hot tumors: from molecular mechanisms to targeted therapy. Signal Transduct Target Ther. 2024;9(1):274. https:\/\/doi.org\/10.1038\/s41392-024-01979-x.","journal-title":"Signal Transduct Target Ther"},{"key":"5245_CR38","doi-asserted-by":"publisher","unstructured":"L, Z, X, L, J, L, et al. Lactylation-mediated fap expression in cancer-associated fibroblasts promotes extracellular matrix remodeling and immune exclusion. Can Res. 2025;85(4):1142\u201358. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-1878.","DOI":"10.1158\/0008-5472.CAN-24-1878"},{"issue":"1","key":"5245_CR39","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13046-025-3418-z","volume":"44","author":"Q Wu","year":"2025","unstructured":"Wu Q, Zhang X, Liu J, Huang S, Chen M. Tumor-derived lactate promotes stromal barrier formation through histone lactylation-induced antxr1 upregulation in colorectal cancer. J Exp Clin Cancer Res. 2025;44(1):112. https:\/\/doi.org\/10.1186\/s13046-025-3418-z.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"5245_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41423-024-0125-x","volume":"22","author":"J Gu","year":"2025","unstructured":"Gu J, Zhou J, Chen X, Wang Z, Liu R, et al. Lactate-induced moesin lactylation at k72 enhances tgf-beta signaling to maintain treg stability and function. Cellular Mol Immunol. 2025;22(3):455\u201371. https:\/\/doi.org\/10.1038\/s41423-024-0125-x.","journal-title":"Cellular Mol Immunol"},{"issue":"1","key":"5245_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12943-025-5098-y","volume":"24","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Wang L, Jiang S, Zhang T. Pik3ca mutations drive a positive feedback loop of mutation-metabolism-epigenetics to sustain the immunosuppressive microenvironment in solid tumors. Mol Cancer. 2025;24(1):89. https:\/\/doi.org\/10.1186\/s12943-025-5098-y.","journal-title":"Mol Cancer"},{"key":"5245_CR42","doi-asserted-by":"publisher","unstructured":"Nakahara M, Arai R, Tokuoka I, et al. Rbm17 promotes the chemoresistance of oral squamous cancer cells through checkpoint kinase 1. Int J Mol Sci. 2025;26(7):3127. https:\/\/doi.org\/10.3390\/ijms26073127.","DOI":"10.3390\/ijms26073127"},{"key":"5245_CR43","doi-asserted-by":"publisher","unstructured":"Han Y, Zhang M, Chen D, et al. Downregulation of rna binding motif protein 17 expression inhibits proliferation of hypopharyngeal carcinoma fadu cells. Oncol Lett. 2018;15(4):5680\u20134. https:\/\/doi.org\/10.3892\/ol.2018.8012.","DOI":"10.3892\/ol.2018.8012"},{"issue":"2","key":"5245_CR44","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jmb.2013.09.037","volume":"426","author":"I Lange","year":"2014","unstructured":"Lange I, Geerts D, Feith DJ, Mocz G, Koster J, Bachmann AS. Novel interaction of ornithine decarboxylase with sepiapterin reductase regulates neuroblastoma cell proliferation. J Mol Biol. 2014;426(2):332\u201346. https:\/\/doi.org\/10.1016\/j.jmb.2013.09.037.","journal-title":"J Mol Biol"},{"issue":"7","key":"5245_CR45","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.3390\/ijms22073464","volume":"22","author":"R Mishra","year":"2021","unstructured":"Mishra R, Patel H, Alanazi S, Kilroy MK, Garrett JT. Pi3k inhibitors in cancer: clinical implications and adverse effects. Int J Mol Sci. 2021;22(7):3464. https:\/\/doi.org\/10.3390\/ijms22073464.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"5245_CR46","doi-asserted-by":"publisher","first-page":"0219180","DOI":"10.1371\/journal.pone.0219180","volume":"5","author":"M Rehan","year":"2019","unstructured":"Rehan M. Anticancer compound xl765 as pi3k\/mtor dual inhibitor: a structural insight into the inhibitory mechanism. Heliyon. 2019;5(10):0219180. https:\/\/doi.org\/10.1371\/journal.pone.0219180.","journal-title":"Heliyon"},{"issue":"6","key":"5245_CR47","doi-asserted-by":"publisher","first-page":"67258","DOI":"10.1371\/journal.pone.0067258","volume":"8","author":"DD Fang","year":"2013","unstructured":"Fang DD, Zhang CC, Gu Y, Jani JP, Cao J, Tsaparikos K, et al. Antitumor efficacy of the dual pi3k\/mtor inhibitor pf-04691502 in a human xenograft tumor model derived from colorectal cancer stem cells harboring a pik3ca mutation. PLoS ONE. 2013;8(6):67258. https:\/\/doi.org\/10.1371\/journal.pone.0067258.","journal-title":"PLoS ONE"},{"issue":"15","key":"5245_CR48","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.3390\/cancers16152671","volume":"16","author":"D van der Graaff","year":"2024","unstructured":"van der Graaff D, Seghers S, Vanclooster P, Deben C, Vandamme T, Prenen H. Advancements in research and treatment applications of patient-derived tumor organoids in colorectal cancer. Cancers. 2024;16(15):2671. https:\/\/doi.org\/10.3390\/cancers16152671.","journal-title":"Cancers"},{"issue":"5","key":"5245_CR49","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3390\/jpm12050695","volume":"12","author":"T Kiwaki","year":"2022","unstructured":"Kiwaki T, Kataoka H. Patient-derived organoids of colorectal cancer: a useful tool for personalized medicine. J Personal Med. 2022;12(5):695. https:\/\/doi.org\/10.3390\/jpm12050695.","journal-title":"J Personal Med"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05245-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05245-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05245-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:36:57Z","timestamp":1788907017000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05245-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5245"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05245-0","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This study utilized only publicly available, de-identified transcriptomic and single-cell RNA sequencing datasets from the TCGA and GEO databases and did not involve any human participants, animal experiments, or identifiable personal information.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1315"}}